Yourway
6681 Snowdrift Road
Allentown, PA 18106
United States
Toll Free:
Fax:
Email:
Phase II results performed at two sites in Israel have demonstrated that ArtemiC, natural supplement and COVID-19 treatment, has met all primary endpoints and helps alleviate symptoms and hospitalization associated with the disease. Roby Zomer, co-founder and CEO of MGC Pharma, noted, “These results, combined with our recent preclinical results, are important for designing the protocols and markers for our next Phase IIb clinical trial.” Yourway has a 7,500 square foot local depot in Tel Aviv, Israel, to provide service to regions in the Middle East and Africa. Our clients are given access to 21 strategic depot locations around the globe, as well as the ability to seamlessly manage inventory through an easy-to-use client portal.
Pfizer and BioNTech’s coronavirus vaccine candidate, BNT162b2, which relies on mRNA (messenger RNA) to teach the immune system to produce antibodies that target the virus, is enrolling participants in a clinical trial in Honolulu, Hawaii. At present, fewer than 20% of participants have experienced side effects. When it comes to clinical trials world and nation-wide, Yourway provides the full scope of our client’s biopharmaceutical storage and distribution needs; outsourcing to a single global provider optimizes supply chain efficiency and minimizes risk.
Beijing health officials have come forward to announce that the country has been inoculating those in high-risk groups and the military with an experimental COVID-19 vaccine since July – prior to completing clinical trials or safety testing. This is an unprecedented move, as clinical trials are crucial in determining whether a vaccine or drug can be tolerated for large-scale consumption. Yourway is making clinical trials more seamless than ever with our direct-to-patient offering, in which clinical trial supplies are delivered directly to and from patients, eliminating the need for trial sites. This offering has been key, especially during the pandemic.
The University of Cambridge has received a £1.9m grant from the UK Government to conduct clinical trials of its COVID-19 vaccine candidate. Trials will take place in the second half of this year or early 2021. Yourway operates a 7,730 square foot regional depot in Heathrow, London, which is in a prime location to serve both the UK and European markets.
The FDA has promised to review Pfizer’s coronavirus vaccine before the November election, as early as this October. Nicholas Kitchin, M.D., a senior director in Pfizer's vaccine R&D group, told the Centers for Disease Control that the clinical trial of the company’s BioNTech-partnered COVID vaccine, BNT162b2, is more than 50% enrolled. A premium clinical supplies courier, Yourway helps crucial vaccine supplies reach their destinations around the world to facilitate faster trials.